Zymeworks guides FY26 total sales of $278M-$292M, adjusted EBITDA of $114M-$128M

Zymeworks guided to FY26 total sales, including collaboration revenue from YUPELRI, of $278M-$292M, with adjusted EBITDA of $114M-$128M.

Detected & updated continuously · Source: Nebula